Company news
Rxsight, Inc. (NASDAQ:RXST) news
Every Rxsight, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
RxSight, Inc. to Participate in the Wells Fargo Healthcare Conference
August 26, 2026
RxSight, Inc. Reports Second Quarter 2026 Results and Provides Update on 2026 Outlook
August 5, 2026
RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
July 26, 2026
RxSight Announces Appointments of Aziz Mottiwala as Chief Executive Officer and Ron Kurtz, M.D. as Chief Medical Officer
July 15, 2026
RxSight, Inc. Announces Preliminary Second Quarter Financial Results and Product Pipeline Updates Following Strategic Collaboration Agreement
July 6, 2026
Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs
July 6, 2026
RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook
May 6, 2026
RxSight, Inc. to Report First Quarter 2026 Financial Results on May 6
April 22, 2026
RxSight Highlights 300,000 Light Adjustable Lens Implant Milestone and Strong Scientific Presence at ASCRS 2026
April 8, 2026
RxSight, Inc. to Participate in the 25th Annual Needham Virtual Healthcare Conference
April 2, 2026
RXSight, Inc. Reports Fourth Quarter and 2025 Results; Issues 2026 Guidance
February 25, 2026
RxSight, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026
February 11, 2026
RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer
January 11, 2026
RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference
January 2, 2026
RxSight, Inc. Announces Chief Financial Officer Transition
December 22, 2025
RxSight, Inc. to Present at the Piper Sandler Healthcare Conference
November 20, 2025
RxSight, Inc. Reports Third Quarter 2025 Financial Results
November 5, 2025
RxSight, Inc. to Report Third Quarter 2025 Financial Results on November 5, 2025
October 22, 2025
RxSight, Inc. to Feature Live Learning Sessions at American Academy of Ophthalmology 2025 Annual Meeting
October 16, 2025
RxSight, Inc. to Present at the Morgan Stanley Healthcare Conference
August 25, 2025
RxSight, Inc. to Present at the Wells Fargo Healthcare Conference
August 14, 2025
RxSight, Inc. Reports Second Quarter 2025 Financial Results
August 7, 2025
RxSight, Inc. Appoints Raymond W. Cohen to Its Board of Directors
August 4, 2025
RxSight, Inc. to Report Second Quarter 2025 Financial Results on August 7, 2025
July 24, 2025
RxSight, Inc. Announces Preliminary Second Quarter 2025 Revenue and Revised 2025 Guidance
July 8, 2025
RxSight, Inc. to Participate in the Stifel 2025 Virtual Ophthalmology Forum
May 20, 2025
RxSight, Inc. Reports First Quarter 2025 Financial Results
May 7, 2025
RxSight, Inc. to Present at the Bank of America Healthcare Conference
April 30, 2025
RxSight, Inc. to Report First Quarter 2025 Financial Results on May 7, 2025
April 23, 2025
RxSight, Inc. Announces Preliminary First Quarter 2025 Revenue and Revised 2025 Guidance
April 1, 2025
RxSight, Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference
March 25, 2025
RxSight, Inc. Reports Fourth Quarter and Full-Year 2024 Financial Results, Reaffirms 2025 Guidance
February 25, 2025
RxSight, Inc. to Report Fourth Quarter Financial Results on February 25, 2025
February 11, 2025
RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial and Operational Results and 2025 Guidance
January 12, 2025
RxSight, Inc. Reports Third Quarter 2024 Financial Results
November 7, 2024
RxSight, Inc. to Report Third Quarter Financial Results on November 7, 2024
October 24, 2024
RxSight, Inc. to Participate in Upcoming Morgan Stanley and Wells Fargo Healthcare Conferences
August 22, 2024
RxSight, Inc. Reports Second Quarter 2024 Financial Results
August 5, 2024
RxSight, Inc. to Report Second Quarter Financial Results on August 5, 2024
July 22, 2024
RxSight, Inc. To Participate in the Truist Securities Medtech Conference
June 5, 2024
RxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
May 13, 2024
RxSight, Inc. Announces Proposed Public Offering of Common Stock
May 8, 2024
RxSight, Inc. Announces Pricing of Public Offering of Common Stock
May 8, 2024
RxSight, Inc. Reports First Quarter 2024 Financial Results
May 6, 2024
RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024
April 22, 2024
RxSight Announces Commercial Launch of its Newest Light Adjustable Lens™, the LAL+™, and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting
April 4, 2024
RxSight, Inc. to Participate in the 23rd Annual Needham Virtual Healthcare Conference
March 27, 2024
RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference
February 29, 2024
RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
February 28, 2024
RxSight, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
February 14, 2024